Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18500245.
- Also identified by DOI 10.1038/nrc2396 and PMC identifier 2711846.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The maintenance and preservation of distinct phases during the cell cycle is a highly complex and coordinated process. It is regulated by phosphorylation--through the activity of cyclin-dependent kinases (CDKs)--and protein degradation, which occurs through ubiquitin ligases such as SCF (SKP1-CUL1-F-box protein) complexes and APC/C (anaphase-promoting complex/cyclosome). Here, we explore the functionality and biology of the F-box proteins, SKP2 (S-phase kinase-associated protein 2) and beta-TrCP (beta-transducin repeat-containing protein), which are emerging as important players in cancer biogenesis owing to the deregulated proteolysis of their substrates.
Medical subject headings
- Neoplasm Proteins
- Neoplasms
- S-Phase Kinase-Associated Proteins
- beta-Transducin Repeat-Containing Proteins